EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis

Ivan C N Fung iD, Pim J Koelink iD, Lieven G M Mulders iD, Iris Admiraal iD, Caroline Verseijden iD, Jan Verhoeff iD, Manon E Wildenberg iD, Yi Luo, Geert R D'Haens iD, Andrew Y F Li Yim iD, Wouter J de Jonge iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Ivan C N Fung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Intestinal Mucosa, B-Lymphocytes, Colitis, Ulcerative, Colitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol-Myers Squibb. While Bristol-Myers Squibb, Bristol-Myers Squibb, Janssen Prevention Center of Janssen Vaccines & Prevention BV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by relapsing and remitting mucosal inflammation of the colon. While active UC mucosa is characterized by dysregulated B cell responses and increased B cell and IgG plasma cell populations, targeting CD20-expressing B cells in UC has proven ineffective.

Methods

We conducted an exploratory single-cell transcriptomic analysis of colonic biopsies obtained from UC patients with (n = 5) or without (n = 5) active inflammation, and non-UC controls (n = 4). To explore whether B cells contribute to colitis severity, we transferred various ratios of spleen-derived naive B cells with CD45RBhigh T cells into severe combined immune deficient mice to induce colitis.

Results

Our analysis identified a distinct subset of naive (MS4A1+CD27-IGHD+TCL1A+) B cells that are significantly enriched and present a more matured phenotype in inflamed compared to non-inflamed biopsies from UC patients. Cell-cell communication analysis indicated that naive B cells interacted predominantly with CD4+ T cell subsets. In the mice transfer colitis model, co-transfer of naive B cells at a ratio of 1-2 T and B cells, respectively, showed an increased maturation and activity, which led to exacerbation of colitis as measured by weight loss, increased colon density, and histological inflammation.

Conclusion

Our findings suggest that naive B cells expand in actively inflamed mucosa from UC patients and play a pathogenic role in experimental colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal MucosaB-LymphocytesColitis, UlcerativeColitisHumansAnimalsMiceFemaleMaleDisease Models, AnimalCase-Control StudiesMiddle AgedAdultMice, SCIDCD4-Positive T-LymphocytesColon

Stichwörter der Autor:innen

B cell maturation and expansionB cell pathologymice colitis transfer modelsingle-cell RNA-sequencingulcerative colitis

Autor:innen und Institutionen

  • Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam University Medical Centers, Free University Amsterdam, Amsterdam, The Netherlands.
  • Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Department of ImmunePathophysiology and Surgery, University of Bonn, Bonn, Germany.

ORCID-Profile: Ivan C N Fung, Pim J Koelink, Lieven G M Mulders, Iris Admiraal, Caroline Verseijden, Jan Verhoeff, Manon E Wildenberg, Geert R D'Haens, Andrew Y F Li Yim, Wouter J de Jonge

Förderung

  • Bristol-Myers Squibb. While Bristol-Myers Squibb
  • Bristol-Myers Squibb
  • Janssen Prevention Center of Janssen Vaccines & Prevention BV
  • Janssen Pharmaceutical Companies of Johnson & Johnson

Zitieren

APA

Fung, I. C. N., Koelink, P. J., Mulders, L. G. M., Admiraal, I., Verseijden, C., Verhoeff, J., Wildenberg, M. E., Luo, Y., D'Haens, G. R., Li Yim, A. Y. F., & de Jonge, W. J. (2026). Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf275

Vancouver

Fung ICN, Koelink PJ, Mulders LGM, Admiraal I, Verseijden C, Verhoeff J, et al. Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf275

BibTeX
@article{Fung2026,
  author = {Fung, Ivan C N and Koelink, Pim J and Mulders, Lieven G M and Admiraal, Iris and Verseijden, Caroline and Verhoeff, Jan and Wildenberg, Manon E and Luo, Yi and D'Haens, Geert R and Li Yim, Andrew Y F and de Jonge, Wouter J},
  title = {Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf275}
}
Kostenlos starten →